Get started
Work

Figure 2 from First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors

Year: 2025
Type: other
Abstract: Geometric mean (gSD) serum concentrations (μg/mL) of AZD8853 vs. time (semilogarithmic scale) – PK set. Vertical lines represent the geometric mean ± gSD. Geometric mean − gSD: exp (mean[log(PK Conc)] − std [log(PK Conc)]). Geometric mean + gSD: exp (mean[log(PK Conc)] + std [log(PK Conc)]). C, cycle; D, day; gSD, geometric SD; PK Conc, PK concentration.
DOI: 10.1158/2767-9764.29209918
Authors: Benedito A. Carneiro, Olumide B. Gbolahan, Albiruni Abdul Abdul Razak, John F. Hilton, Arthur W. Lambert, John Hood, Michael Pluta, Veronique Bragulat, Elhan Sanai, Rakesh Kumar, Duncan I. Jodrell, Patricia M. LoRusso
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4410967492
Cites:
Cited by:
Related to: 10